Spotlight | Morocco
The enigmatic businessman targeted by the Emirati sovereign fund
Abu Dhabi's Mubadala sovereign wealth fund has taken legal action against representatives of a subsidiary of Kelix Bio, a pharmaceutical investment platform it acquired in 2024. The financial dispute centres on a young Moroccan-British facilitator.